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“it's not the years in your life that matters, it's the life in your years”
This (mis)quote neatly captures the importance of quality of life. Indeed, our quality 
of life has perhaps never been so important than during these unprecedented times 
of the COVID-19 pandemic. 
Although limited, there is some empirical evidence to support the value that people 
with heart disease attach to their health-related quality of life (HRQoL). An innovative 
study asked 99 people with advanced heart failure to complete a time trade-off 
(TTO) tool to quantify their willingness to trade time (length of life) for better health 
(HRQoL) [1]. TTO scores can range from 1.0 (no willingness to trade off length of life 
for health) to 0 (complete willingness to trade off length of life for health). Importantly, 
the study authors found that patients were prepared to trade off time for health and, 
interestingly, this trade off was greatest for those with the poorest HRQoL (e.g. 
patients with a NYHA score of IV reported a mean TTO score of 0.66-0.69). Whilst 
‘hard’ clinical trial outcomes such mortality and hospitalisation have traditionally been 
used to judge the value of new and existing treatments for heart disease, there is an 
increasing call for the regulatory approval of new treatments to include formal 
consideration of impacts on patient-related outcomes, especially HRQoL [2].
When we ask our patients why they want to participate in cardiac rehabilitation (CR), 
the response that invariably hear is that they do so because they want to be able to 
better undertake their activities and roles of daily life – in other words, patients 
undertake CR to improve their HRQoL. This is also reflected in the core standards of 
the British Association for Cardiovascular Prevention and Rehabilitation noting that 
whilst optimal medical therapy and percutaneous intervention for management of 
coronary heart disease add ‘years to life’, the potential for CR to add ‘life to years’ 
should not be underestimated’ [3].
Although we have evidence from our Cochrane review of randomised controlled 
trials that, overall, people with coronary heart disease following CR have superior 
HRQoL compared to (no CR) controls, the strength of this evidence is not all that we 
might want it to be [4, 5]. To date, only few trials (20 trials in 5,060 patients out of 63 
trials randomising 14,486 patients) have collected and reported HRQoL and, when 
https://mc.manuscriptcentral.com/heart
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Heart
they do, there has been little consistency in the HRQoL outcomes collected, often 
limited to short term follow up.  
This study by Hurdus and colleagues published in the current issue of ‘Heart’ 
provides important confirmatory evidence of the benefits of CR on the HRQoL [6] 
The study was based on a large longitudinal prospective cohort study (Evaluation of 
the Methods and Management of Acute Coronary Events (EMMACE)-3) with data on 
the referral and uptake of CR in England from 4,570 patients admitted with an acute 
myocardial infraction between 1st November 2011 and 17th September 2013. 
Uniquely, this study provides repeated measures data on the impact of CR on 
HRQoL collected using the EQ-5D-3L at hospitalisation, 30 days, 6-months and 12-
months following hospital discharge. Across all AMI patients, the authors report a 
small improvement in mean EQ-5D index score from hospitalisation to 12 months 
(0.744 vs. 0.794). They also found that those who attended CR had greater mean 
EQ-5D score at 12-months (12 months (0.832 vs. 0.739) and consistent over time 
following hospitalisation. These HRQoL improvements with CR participation were not 
only statistically significant but also clinically important. Reassuringly, the Hurdus et 
al also found those achieving in ≥150 minutes of activity per week (a marker of CR 
adherence), achieved the largest improvements in HRQoL. Although the authors 
acknowledge that these observational findings of require confirmation in a 
randomised trial, robust scientific methods were employed by this study group - 
potential selection bias and confounding minimised by use of a weighted propensity 
score analysis. 
As recognised in a recent editorial, we still have much work to do to agree upon what 
level of improvement of HRQoL we would exchange for a reduction in quantity of life 
[7]. However, in the meantime, future evidence collection (trials and observational 
studies) assessing the impact CR, need to assess and report HRQoL – using 
generic and disease specific instruments. Although challenging, consensus in the 
CR field on the HRQoL measures that we should collect, would aid this endeavour, 
and allow us directly compare results between studies and pool data across studies 
using standard meta-analytic approaches.
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